The files are password protected for members.  Please contact us if you forgot your username and password or for new members, to obtain one.  Click on the highlighted/colored portion to open. Some of these are large files and may take a some time to download and open. They should open in Adobe Acrobat Reader.  You will need Adobe Acrobat Reader (free download from Adobe).  If the file does not appear, or adobe opens but you get a blank screen, (primarily for Acrobat 5.0 Reader users in Internet Explorer 6.0 and NT or XP systems), you will need to open Acrobat Reader, and select preferences in the Edit menu.  Click options and uncheck the open in browser box if checked.  This should fix the problem and Adobe files will open in a new window.    Clicking the back button when finished viewing the file will return you to the summaries page if it opened in the browser.  If opened in a new window, simply close the window to return to the SFAI summaries page.

March 30, 2005

Estrogen receptor analysis of breast cancer:  Is quantiative better?:  Dr. Allen Gown

Application of Silver Based Chromogenic In-situ Hybridization (SISH) and IHC to Surgical Pathology Diagnosis (2 parts):  Drs. Thomas Grogan and Richard N. Eisen

FISH Analysis of Tumors With Quantitative Methods:  Dr. Allen Gown

October 4, 2003

Neurodegenerative diseaeses and IHC:  Dr. Mark Edgar

CNS Tumors and IHC:  Dr. Mark Edgar

Identification and Treatment of Prion Diseases:  Dr. Richard Kascsak

Alzheimer's Disease: Therapeutic Strategies:   Dr. Thomas Wisniewski

Comparative Veterinary Oncology and Pathology:  Dr. Philip Bergman

Emerging Infectious Diseaes and IHC:  Dr. Sherif Zaki

May 21, 2003

P16 IHC in Cervical Smears and Surgical Material:  Dr. William J. Klump

CDX2: A New Marker of Intestinal Differentiation:  Drs. Richard W. Cartun and Richard N. Eisen

CK 7 Positive, CK20 Negative Colon Carcinomas:  Dr. Neal Goldstein

Synthetic peptides as novel quality control for quantitative IHC:  Dr. Steven Bogen:  coming soon

October 26, 2002

Bioinformatics and Breast Cancer:  Dr. Federico Monzon

The ErbB Family: Therapeutic Target and Diagnostic Dilemma:  Albert J. Kovatich, MS

Biomarkers in DCIS:  Dr. Juan Palazzo

Optimal Fixation Times for ER Analysis:  Dr. Neal Goldstein

Phosphorylated Her-2/neu and EGFR as prognostic factors in breast cancer:  Dr. Michael DiGiovanna

July 17, 2002

Pulmonary Neoplasia and Mesothelioma Update:  Dr. Douglas Flieder

May 22, 2001

MUC proteins and neoplasia: Dr. Volkan Adsay

P504S: A novel marker of prostate cancer: Dr. Zhong Jiang

P63: Immunohistochemical applications: Dr. Allen Gown

Sept. 8, 2001

Dr. Mark Wick:

Prognostic and Predictive Tests in Anatomic Pathology

Immunohistology in Neoplastic Dermatopathology

Diagnostic Immunohistology in Selected Urologic Neoplasms

Diagnostic Immunohistology in Urologic Path

Dr. Rodney Miller:

Technical Immunohistochemistry

Meeting:   January 17, 2001

Case Presentation: Dr. James Weisberger

Gynecologic Pathology and IPOX update: Dr. Robert Soslow

WT1 antibody and diagnostic pathology: Dr. Allen Gown

Meeting:  November 4, 2000

Prognostic Markers in Colorectal Cancer: Juan Palazzo, M.D.

Hereditary Non-Polyposis Colorectal Carcinoma: Dr. Tina Bocker Edmonston

The Use of Cytokeratins in GE Junction Pathology: Dr. Robert Odze, M.D.

Immunohistochemistry of Pancreaticobiliary Adenocarcinomas: Neal Goldstein, M.D.

Liver from Bone Marrow in Humans: Dr. Neil Theise

 1-Canals of Hering and Stem Cells

2-Liver from mouse bone marrow

3-Liver from human bone marrow

Meeting:  July 26, 2000

The Workup of Renal Biopsies:  Dr. Vivette D'Agati

Meeting: April 19, 2000

Case Presentations:  Metastases to the GI Tract : Dr. Federico Monzon

A Holistic Approach to Antigen Retrieval: David Tacha, HT/HTL (ASCP)

Chemokines in Hodgkin's Disease: Dr. Julie Teruya-Feldstein